BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29533023)

  • 21. Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Petrillo M; De Iaco P; Cianci S; Perrone M; Costantini B; Ronsini C; Scambia G; Fagotti A
    Ann Surg Oncol; 2016 May; 23(5):1660-5. PubMed ID: 26714958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential survival benefit of secondary cytoreductive surgery for recurrent epithelial ovarian, tubal, and peritoneal cancers.
    Goto T; Takano M; Watanabe A; Miyamoto M; Kato M; Hirata J; Sasa H; Furuya K
    Int J Gynecol Cancer; 2011 Feb; 21(2):263-8. PubMed ID: 21270609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer.
    Katsnelson M; Hwang WT; Tahirovic E; Rubin SC; Tanyi JL
    J Obstet Gynaecol; 2018 Apr; 38(3):395-401. PubMed ID: 29385863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer.
    Fanfani F; Monterossi G; Fagotti A; Gallotta V; Costantini B; Vizzielli G; Petrillo M; Carbone MV; Scambia G
    Ann Surg Oncol; 2015 Feb; 22(2):649-54. PubMed ID: 25155399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis.
    Ding T; Tang D; Xi M
    J Ovarian Res; 2021 Jul; 14(1):93. PubMed ID: 34256813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer.
    Jiang C; Li Z
    Front Oncol; 2021; 11():674637. PubMed ID: 34631517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001).
    Son JH; Kong TW; Park SJ; Lee EJ; Kim HS; Kim NK; Kim Y; Hwang WY; Suh DH; Kim TH; Yang EJ; Shim SH; Chang SJ
    J Surg Oncol; 2023 Sep; 128(4):645-652. PubMed ID: 37126413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting non-home discharge in epithelial ovarian cancer patients: External validation of a predictive model.
    Connor EV; Newlin EM; Jelovsek JE; AlHilli MM
    Gynecol Oncol; 2018 Oct; 151(1):129-133. PubMed ID: 30107886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When should Surgery be used for Recurrent Ovarian Carcinoma?
    Bommert M; Harter P; Heitz F; du Bois A
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):493-497. PubMed ID: 29743148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study.
    Marchetti C; De Leo R; Musella A; D'Indinosante M; Capoluongo E; Minucci A; Benedetti Panici P; Scambia G; Fagotti A
    Ann Surg Oncol; 2018 Nov; 25(12):3701-3708. PubMed ID: 30128899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
    Chesnais M; Lecuru F; Mimouni M; Ngo C; Fauconnier A; Huchon C
    PLoS One; 2017; 12(11):e0187245. PubMed ID: 29117194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
    Paik ES; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
    J Gynecol Oncol; 2016 May; 27(3):e24. PubMed ID: 27029745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
    Li YF; Li MD; Liu FY; Liu JH; Li JD
    Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.
    Eriksson AGZ; Graul A; Yu MC; Halko A; Chi DS; Zivanovic O; Gardner GJ; Sonoda Y; Barakat RR; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2017 Aug; 146(2):263-267. PubMed ID: 28527673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.
    Straubhar AM; Wolf JL; Zhou MQC; Iasonos A; Cham S; Wright JD; Long Roche K; Chi DS; Zivanovic O
    Gynecol Oncol; 2021 Feb; 160(2):438-444. PubMed ID: 33272645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary complete cytoreduction in recurrent ovarian cancer: benefit of optimal patient selection using scoring system.
    Laas E; Luyckx M; De Cuypere M; Selle F; Daraï E; Querleu D; Rouzier R; Chéreau E
    Int J Gynecol Cancer; 2014 Feb; 24(2):238-46. PubMed ID: 24457552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transitory Stoma at the Time of Complete Cytoreductive Surgery Affects Survival for Patients with Advanced-stage Ovarian Cancer.
    Canlorbe G; Touboul C; Chargari C; Bentivegna E; Maulard A; Pautier P; Genestie C; Morice P; Gouy S
    Anticancer Res; 2018 Mar; 38(3):1517-1523. PubMed ID: 29491080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer?
    Fanfani F; Fagotti A; Ercoli A; Gallotta V; Chiantera V; Restaino S; Monterossi G; Scambia G
    Anticancer Res; 2015 Dec; 35(12):6951-5. PubMed ID: 26637921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
    Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
    Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.